IN2014MN01376A - - Google Patents

Info

Publication number
IN2014MN01376A
IN2014MN01376A IN1376MUN2014A IN2014MN01376A IN 2014MN01376 A IN2014MN01376 A IN 2014MN01376A IN 1376MUN2014 A IN1376MUN2014 A IN 1376MUN2014A IN 2014MN01376 A IN2014MN01376 A IN 2014MN01376A
Authority
IN
India
Prior art keywords
ihmvyskrsgkprgyafiey
peptide
salt
amino acid
acid sequence
Prior art date
Application number
Inventor
Sylviane Muller
Jean Paul Briand
Robert Zimmer
Original Assignee
Centre Nat Rech Scient
Immupharma France Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Immupharma France Sa filed Critical Centre Nat Rech Scient
Publication of IN2014MN01376A publication Critical patent/IN2014MN01376A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)

Abstract

The present invention relates to a peptide or a salt thereof comprising or consisting of the amino acid sequence IHMVYSKRSGKPRGYAFIEY comprising one or more post translational modifications.
IN1376MUN2014 2011-12-13 2011-12-13 IN2014MN01376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2011/003256 WO2013088194A1 (en) 2011-12-13 2011-12-13 Modified peptides and their use for treating autoimmune diseases

Publications (1)

Publication Number Publication Date
IN2014MN01376A true IN2014MN01376A (en) 2015-04-17

Family

ID=45607295

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1376MUN2014 IN2014MN01376A (en) 2011-12-13 2011-12-13

Country Status (14)

Country Link
US (2) US9657072B2 (en)
EP (2) EP2790715B1 (en)
JP (1) JP6060175B2 (en)
KR (2) KR20170020556A (en)
CN (2) CN106986927A (en)
AU (2) AU2011383222C1 (en)
BR (1) BR112014014492B1 (en)
CA (1) CA2858957C (en)
DK (2) DK2790715T3 (en)
ES (1) ES2618402T3 (en)
HU (1) HUE032552T2 (en)
IN (1) IN2014MN01376A (en)
RU (1) RU2620070C2 (en)
WO (1) WO2013088194A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10213482B2 (en) * 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases
CN109312379B (en) 2016-04-05 2022-04-12 科学与工业研究委员会 Multifunctional recombinant nucleotide-dependent glycosyltransferase proteins and methods for their glycosylation
WO2018109285A1 (en) * 2016-12-13 2018-06-21 Centre National De La Recherche Scientifique Peptides for the treatment of neurolupus
US20210308211A1 (en) * 2020-03-29 2021-10-07 Immupharma France Sa Method of treating viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
PT1425295E (en) * 2001-09-06 2010-03-24 Centre Nat Rech Scient Modified peptides and their use for the treatment of autoimmune diseases
FR2829768B1 (en) * 2001-09-18 2003-12-12 Centre Nat Rech Scient USE OF PEPTIDES COMPRISING POST-TRANSLATIONAL TYPE MODIFICATIONS IN THE TREATMENT OF AUTOIMMUNE CONDITIONS
KR101722305B1 (en) * 2007-01-30 2017-03-31 에피백스, 인크. Regulatory t cell epitopes, compositions and uses thereof
FR2931360B1 (en) * 2008-05-20 2012-05-18 Centre Nat Rech Scient NANOPARTICLES CONTAINING A PEPTIDE, VECTORS CONTAINING SAME AND PHARMACEUTICAL USES OF SAID NANOPARTICLES AND VECTORS

Also Published As

Publication number Publication date
BR112014014492A2 (en) 2020-10-27
CN104114180B (en) 2017-01-18
EP3202413A1 (en) 2017-08-09
EP2790715A1 (en) 2014-10-22
AU2011383222A1 (en) 2014-07-03
DK3202413T3 (en) 2018-11-19
JP6060175B2 (en) 2017-01-11
RU2014128612A (en) 2016-02-10
CA2858957A1 (en) 2013-06-20
CN106986927A (en) 2017-07-28
JP2015501831A (en) 2015-01-19
CA2858957C (en) 2019-09-03
BR112014014492B1 (en) 2022-05-24
AU2011383222B2 (en) 2016-10-27
US9657072B2 (en) 2017-05-23
US20170226167A1 (en) 2017-08-10
US20150111835A1 (en) 2015-04-23
DK2790715T3 (en) 2017-03-20
AU2017200207B2 (en) 2018-03-01
EP3202413B1 (en) 2018-08-01
HUE032552T2 (en) 2017-09-28
ES2618402T3 (en) 2017-06-21
EP2790715B1 (en) 2016-12-07
CN104114180A (en) 2014-10-22
RU2620070C2 (en) 2017-05-22
AU2011383222C1 (en) 2017-04-20
WO2013088194A1 (en) 2013-06-20
KR20170020556A (en) 2017-02-22
KR101728784B1 (en) 2017-04-21
AU2017200207A1 (en) 2017-02-02
KR20140114365A (en) 2014-09-26

Similar Documents

Publication Publication Date Title
IL274204B (en) Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
IL239425A0 (en) Zinc amino acid halide mouthwashes
IL229353A0 (en) Compositions containing ,methods involving ,and uses of non-natural amino acid linked dolastatin deriv atives
EP2771033A4 (en) Protein formulations containing amino acids
ZA201503846B (en) Zinc amino acid/trimethylglycine halide
GB201315335D0 (en) Amino diacids containing peptide modifiers
MY167847A (en) Intra-mode video coding
IL231824A0 (en) Etanercept formulations stabilized with amino acids
AU2011356210A8 (en) Novel fucosyltransferases and their applications
CO6900146A2 (en) Amino substituted imidazopyridazines
DK2797616T3 (en) CELL-PENETRATING PEPTIDES
UA118167C2 (en) Peptides and their use
IL238777A0 (en) Dermal compositions containing unnatural hygroscopic amino acids
WO2013000922A9 (en) Ccr2 antagonist peptides
BR112013024784A2 (en) long acting peptide analogs
GB201111183D0 (en) Peptide
EP2813488A4 (en) AMINO ACID DERIVATIVE OF ION AMPHOTERE TYPE
SG10201606218WA (en) Purified Proteins
IN2014DN09367A (en)
MX351610B (en) ACID ADDITION SALTS OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYL AMINO]CHOLESTAN-3ß-OL.
EP2646458A4 (en) DEUTERATED PEPTIDES
IN2014MN01376A (en)
MX362393B (en) Expression cassette.
EP3067430A4 (en) Method for producing d-form or l-form amino acid derivative having thiol group
GB201223114D0 (en) Novel peptide